Mr. Akash Vikal | Nanotechnology and Advanced Materials | Innovative Research Award

Mr. Akash Vikal | Nanotechnology and Advanced Materials | Innovative Research Award

IFTM University, Moradabad, India

Akash Vikal is an emerging pharmaceutical researcher specializing in pharmaceutics, nanomedicine, advanced drug delivery systems, and cancer therapeutics. His academic and research contributions primarily focus on the development of innovative formulation strategies designed to improve therapeutic efficacy, targeted delivery, and patient outcomes. Through extensive research in liposomal formulations, nanocarriers, gene delivery systems, and ocular therapeutics, he has established himself as a promising young contributor to modern pharmaceutical sciences.His research portfolio reflects interdisciplinary expertise integrating pharmaceutical technology, nanotechnology, oncology, ophthalmic therapeutics, and translational medicine. With numerous peer-reviewed publications, book chapters, and scientific presentations, he has actively contributed to advancing pharmaceutical innovation and drug delivery research.

Professional Profile 

Education

Akash Vikal completed a Bachelor of Pharmacy (B.Pharm.) from Shri Gopichand College of Pharmacy with strong academic performance. He further pursued a Master of Pharmacy (M.Pharm.) in Pharmaceutics from ISF College of Pharmacy, where he specialized in advanced pharmaceutical formulation and drug delivery systems. His postgraduate research focused on the “Development and Characterization of Ferulic Acid and Docetaxel Loaded Liposomes Against Breast Cancer” under the guidance of Balak Das Kurmi.

Professional Experience

During his academic journey, Akash Vikal gained industrial exposure through internship training at HIS Pharmaceuticals Pvt. Ltd., where he developed practical knowledge related to pharmaceutical manufacturing and formulation processes. He has also actively contributed to scientific communication and peer-review activities, including reviewing submissions for reputed journals such as Dovepress journals Clinical Ophthalmology and Eye and Brain. In addition, he delivered an academic webinar on scientific writing and publication strategies for researchers and healthcare professionals.

Research Interest

He has contributed extensively to pharmaceutical and biomedical research through numerous publications in reputed international journals. His research covers areas such as metal-organic frameworks in drug delivery, PROTAC-based cancer therapy, nanoparticle-mediated antimicrobial strategies, CRISPR-assisted nanotechnology, nanocarrier systems for ocular therapeutics, and phytoconstituent-based anticancer therapies. Several of his works have been published in recognized journals including Applied Materials Today, Drug Delivery and Translational Research, AAPS PharmSciTech, Current Pharmaceutical Design, and Experimental Eye Research.

Award and Honor

Akash Vikal has received recognition for his academic and scientific contributions through participation in national and international conferences, workshops, and faculty development programs. He earned a Certificate of Excellence in Peer Reviewing for his contribution to academic quality enhancement. His involvement in intellectual property awareness programs, pharmaceutical research conferences, and specialized training workshops reflects his commitment to continuous professional development and scientific advancement.

Conclusion

Mebratu Tafesse Teferi demonstrates strong potential for the Best Researcher Award. His substantial academic qualifications, leadership experience, and dedication to educational research are commendable. His publications reflect significant contributions to Ethiopian education and leadership studies, making him a valuable candidate for the award. To further enhance his candidacy, Mebratu could focus on broadening his research scope, fostering international collaborations, and increasing his publication reach in globally recognized journals.

Publications Top Noted

  • Next-generation gene editing strategies in cancer: Integrating CRISPR, PROTACs, and advanced molecular technologies
    Authors: Akash Vikal, Rashmi Maurya, Pradeep Kumar, Navneet Verma, Arun Kumar Mishra
    Year: 2026
  • Liposomal Paclitaxel in Breast Cancer Therapy: Advances, Clinical Insights, and Future Perspectives
    Authors: Akash Vikal, Rashmi Maurya, Navneet Verma, Arun Kumar Mishra
    Year: 2026
  • A Mini-Review on Unlocking Cognitive Enhancement: An Innovative Strategy for Optimal Brain Functions
    Authors: Akash Vikal, Rashmi Maurya, Brij Bihari Patel, Preeti Patel, Manish Kumar, Balak Das Kurmi
    Year: 2025
  • Andrographis paniculata in Fatty Liver Disease: Mechanisms, Nanocarrier Approaches, and Therapeutic Potential
    Authors: Akash Vikal, Rashmi Maurya, Preeti Patel, Balak Das Kurmi
    Year: 2025
  • Development of Mucopenetrating Pegylated Liposomes Functionalized with Sodium Taurocholate for Enhanced Oral Insulin Delivery
    Authors: Akash Vikal, Rashmi Maurya, Balak Das Kurmi, S. Jindal, R. K. Narang
    Year: 2025
  • From Resistance to Response: Metallic Nanoparticles as Game Changers in Triple Negative Breast Cancer Therapy
    Authors: Akash Vikal, Rashmi Maurya, Preeti Patel, R. K. Narang, Balak Das Kurmi
    Year: 2025
  • Lutein as a Liver Guardian: Insights into its Hepatoprotective Mechanisms, Bioavailability, and Emerging Therapeutic Roles
    Authors: Akash Vikal, Rashmi Maurya, Preeti Patel, Balak Das Kurmi
    Year: 2025
  • Nanoemulsion Technology in Oral Drug Delivery: A Path to Enhanced Solubility and Bioavailability
    Authors: Akash Vikal, Rashmi Maurya, Preeti Patel, Balak Das Kurmi
    Year: 2025
  • Role of dePEGylation in Vesicular Carriers-Mediated Stimuli-Responsive Drug Delivery to Tumors
    Authors: Akash Vikal, Rashmi Maurya, Abhinav Vashishat, Taqdir Singh, Satyam Khare, Preeti Patel, Balak Das Kurmi
    Year: 2025

 

Subham Preetam | Nano-robots | Editorial Board Member

Mr. Subham Preetam | Nano-robots | Editorial Board Member

Monash University | India

Mr. Subham Preetam is a distinguished Transfusion Medicine specialist recognized for impactful clinical research, academic contributions, and leadership in advancing evidence-based transfusion practices. With an h-index of 17, a research portfolio of 40 documents, and 1,102 citations across 904 citing documents, Mr. Preetam has established a strong scientific footprint in areas such as apheresis, patient blood management, therapeutic plasma exchange, leukocytapheresis, immunohematology, and transfusion safety. His academic journey includes an MBBS, an MD in Transfusion Medicine, and advanced clinical training through a PDCC in Apheresis and Blood Component Therapy. Professionally, he has served as Senior Resident and faculty in leading national medical institutes, contributing significantly to service development, SOP formulation, staff training, and quality systems in transfusion services. His research interests span clinical apheresis, hemovigilance, transfusion reactions, donor health, PBM strategies, and improving transfusion outcomes. Mr. Preetam has earned recognition through prestigious national awards and has contributed to international working groups, editorial activities, invited sessions, and collaborative projects that strengthen global transfusion medicine practices. His continued dedication reflects a commitment to improving clinical standards, fostering academic excellence, and promoting innovation in transfusion medicine for enhanced patient care.

Profiles: Scopus | Orcid

Featured Publications

Preetam, S., Lata, S., Aditi, Bora, J., Thapliyal, S., Mehta, S., Ramniwas, S., Deshwal, R., Rustagi, S., Talukdar, N., et al. (2025). Exosome-driven biohybrid nanorobots: Bridging nature and nanotechnology in biomedical innovation. RSC Advances. https://doi.org/10.1039/D5RA05296C

Dhasmana, A., Santhanam, A., Dhasmana, K., Malik, S., & Preetam, S. (2025). Innovative smart biosensors for cancer theranostics: A new frontier in detection, diagnosis, and beyond. Cancer Treatment and Research Communications. https://doi.org/10.1016/j.ctarc.2025.100911

Dhasmana, A., Dobhal, P., Sati, A., Santhanam, A., Preetam, S., Malik, S., Joshi, N., Rustagi, S., & Deshwal, R. K. (2025). Synthesis of fungal polysaccharide-based nanoemulsions for cancer treatment. RSC Advances. https://doi.org/10.1039/D5RA01349F

Bhattacharya, T., Das, T., Preetam, S., & Chopra, H. (2025). Cutting-edge developments in agro-waste derived carbon nanomaterials and their multifaceted applications in agriculture: Enhancing crop imaging, nutrient efficiency, and plant health. Zeitschrift für Naturforschung C. https://doi.org/10.1515/znc-2024-0205

Preetam, S., Mishra, R., Thapliyal, S., Rustagi, S., Deshwal, R. K., Ramniwas, S., Dhasmana, A., Rajab, B. S., Alghamdi, S., & Malik, S. (2025). Bioactive coatings for cardiovascular stents: Modulating immune response for enhanced performance. ACS Biomaterials Science & Engineering. https://doi.org/10.1021/acsbiomaterials.5c01166